Treat and extend regimen for diabetic macular oedema—a systematic review and meta-analysis
Author:
Publisher
Springer Science and Business Media LLC
Subject
Cellular and Molecular Neuroscience,Sensory Systems,Ophthalmology
Link
https://link.springer.com/content/pdf/10.1007/s00417-022-05770-y.pdf
Reference36 articles.
1. Nguyen QD, Brown DM, Marcus DM et al (2012) Ranibizumab for diabetic macular edema: results from 2 phase III randomized trials: RISE and RIDE. Ophthalmology 119(4):789–801
2. Heier JS, Korobelnik JF, Brown DM et al (2016) Intravitreal aflibercept for diabetic macular edema: 148-week results from the VISTA and VIVID studies. Ophthalmology 123(11):2376–2385
3. Elman MJ, Qin H, Aiello LP et al (2012) Intravitreal ranibizumab for diabetic macular edema with prompt versus deferred laser treatment: three-year randomized trial results. Ophthalmology 119(11):2312–2318
4. Jeon HL, Lee H, Yoon D et al (2020) Burden of diabetic macular oedema in patients receiving antivascular endothelial growth factor therapy in South Korea: a healthcare resource use and cost analysis. BMJ Open 10(12):e042484
5. Ruiz-Moreno JM, de Andrés-Nogales F, Oyagüez I (2020) Cost-consequence analysis of extended loading dose of anti-VEGF treatment in diabetic macular edema patients. BMC Ophthalmol [Internet] 20(1):371. https://doi.org/10.1186/s12886-020-01637-0
Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. LESS IS MORE;Retina;2024-05
2. Safety and Efficacy of Dexamethasone Intravitreal Implant Given Either First-Line or Second-Line in Diabetic Macular Edema;Patient Preference and Adherence;2023-12
3. Diabetic Macular Edema, Clinicopathologic and Keys for Management;Tertiary Care - Medical, Psychosocial, and Environmental Aspects [Working Title];2023-11-15
4. Modified early intensive and treat-and-extend regimen of anti-vascular endothelial growth factor for diabetic macular edema in Taiwan;Scientific Reports;2023-11-07
5. Diabetic Macular Edema – Diagnostics and Treatment Guidelines;Czech and Slovak Ophthalmology;2023-09-20
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3